Not an actual patient.

NERLYNX: The Power to Reduce the Risk of Progression

"Metastatic" means that the cancer has spread beyond the breast and nearby lymph nodes to other parts of the body. NERLYNX is taken with capecitabine (an oral chemotherapy) to help prevent the cancer from spreading any further.

NERLYNX is intended for people with HER2+ mBC who have already been treated with 2 or more HER2-directed therapies for mBC. These may include trastuzumab, T-DM1, and/or pertuzumab (Herceptin®, Kadcyla® and/or Perjeta®).

Download a NERLYNX brochure

Your resource to help you get started on treatment.

The Benefits of NERLYNX + Capecitabine

NERLYNX was studied in a clinical trial of 621 people who had HER2+ mBC and had undergone treatment with 2 or more HER2-directed treatments for mBC. The trial compared people who took NERLYNX plus capecitabine with people who took lapatinib (Tykerb®) plus capecitabine. Participants were randomly selected to receive NERLYNX.

In the clinical trial, NERLYNX plus capecitabine reduced the risk of cancer progressing.*

In the clinical trial, NERLYNX also gave people a longer response to treatment compared with lapatinib plus capecitabine.

Be confident in knowing you have the power to help reduce the risk of progression with NERLYNX.

*These are relative benefits. In absolute numbers, at 12 months, the progression-free survival rate was 29% in the NERLYNX plus capecitabine group vs 15% in the lapatinib plus capecitabine group.

Median of 8.5 months compared to 5.6 months for those taking lapatinib (Tykerb®). The 8.5 and 5.6 months durations were calculated only from the percentage of people that responded to therapy (32.8% in the NERLYNX group vs 26.7% in the lapatinib group).

Mentor Program

If you are considering or have started treatment, and have questions about what to expect, speak with a mentor.

Connect now
Stay Connected

Sign up to learn about support offerings and get updates specific to your HER2+ breast cancer.

Sign up now
See more support programs and services

Select IMPORTANT SAFETY INFORMATION

What is the most important information I should know about NERLYNX (ner links)?

NERLYNX® (neratinib) may cause serious side effects, including:

  • Diarrhea. Diarrhea is a common side effect of NERLYNX, but it can also be severe. You may lose too much body salts and fluid, and get dehydrated. When you start NERLYNX, your healthcare provider should prescribe the medicine loperamide for you during your first 2 months (56 days) of NERLYNX and then as needed. Be sure that your healthcare provider prescribes anti-diarrheals with NERLYNX. Anti-diarrheals must be started with the first dose of NERLYNX.

Please see additional IMPORTANT SAFETY INFORMATION below.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about NERLYNX (ner links)?

NERLYNX® (neratinib) may cause serious side effects, including:

Your healthcare provider may change your dose of NERLYNX, temporarily stop or completely stop NERLYNX if needed to manage your diarrhea.

See "What are the possible side effects of NERLYNX?" for more information about side effects.

What is NERLYNX?

It is not known if NERLYNX is safe and effective in children.

Before taking NERLYNX, tell your healthcare provider about all of your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take medicines used to decrease stomach acid, called proton pump inhibitors or PPIs. You should avoid taking these medicines during treatment with NERLYNX.

What are the possible side effects of NERLYNX?

NERLYNX may cause serious side effects, including:
See "What is the most important information I should know about NERLYNX?"


The most common side effects of NERLYNX when used alone include:

The most common side effects of NERLYNX in combination with capecitabine include:

These are not all of the possible side effects of NERLYNX. For more information, ask your Healthcare Provider.

Tell your doctor if you have any side effects that bother you or that does not go away. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

For Patient Information, please click here.